Vitiligo

Dermatology
3
Pipeline Programs
5
Companies
10
Clinical Trials
3 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

5 companies ranked by most advanced pipeline stage

Pfizer
PfizerNEW YORK, NY
3 programs
1
Crisaborole 2 % Topical OintmentPhase 21 trial
Exposure of mental health condtion of interestN/A1 trial
Exposure of skin cancer of interestN/A1 trial
Active Trials
NCT04953338Completed36,104Est. Oct 2022
NCT04969419Completed75,771Est. Apr 2023
NCT05298033Completed32Est. Apr 2024
CAGE Bio
CAGE BioCA - San Carlos
1 program
1
Drug: CGB-600 gel, experimental drugPhase 11 trial
Active Trials
NCT07357870RecruitingEst. Nov 2026
Teva
TevaIsrael - Petach Tikva
1 program
1
TEV-53408Phase 12 trials
Active Trials
NCT06807463Recruiting48Est. Sep 2027
NCT06625177Active Not Recruiting38Est. Jun 2027
AVITA Medical
AVITA MedicalCA - Valencia
3 programs
Control InterventionN/A1 trial
Melanocyte-Keratinocyte Transplantation and Ultraviolet LampN/A1 trial
RECELL® Autologous Cell Harvesting DeviceN/A1 trial
Active Trials
NCT04547998Completed25Est. Jan 2023
NCT04271501Terminated5Est. Aug 2021
NCT05971381Completed109Est. Jan 2025
Pierre Fabre
Pierre FabreFrance - Aignan
1 program
Test productN/A1 trial
Active Trials
NCT06446063Recruiting50Est. Jun 2025

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
TevaTEV-53408
PfizerCrisaborole 2 % Topical Ointment
CAGE BioDrug: CGB-600 gel, experimental drug
TevaTEV-53408
Pierre FabreTest product
AVITA MedicalRECELL® Autologous Cell Harvesting Device
PfizerExposure of skin cancer of interest
PfizerExposure of mental health condtion of interest
AVITA MedicalMelanocyte-Keratinocyte Transplantation and Ultraviolet Lamp
AVITA MedicalControl Intervention

Clinical Trials (10)

Total enrollment: 112,182 patients across 10 trials

NCT06807463TevaTEV-53408

A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease

Start: Mar 2025Est. completion: Sep 202748 patients
Phase 2Recruiting
NCT05298033PfizerCrisaborole 2 % Topical Ointment

Study of Efficacy, Safety and Tolerability of Crisaborole and PF-07038124 With and Without NBUVB in Vitiligo

Start: Sep 2022Est. completion: Apr 202432 patients
Phase 2Completed
NCT07357870CAGE BioDrug: CGB-600 gel, experimental drug

A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo

Start: Jul 2025Est. completion: Nov 2026
Phase 1Recruiting
NCT06625177TevaTEV-53408

A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo

Start: Nov 2024Est. completion: Jun 202738 patients
Phase 1Active Not Recruiting
NCT06446063Pierre FabreTest product

Efficacy & Tolerance of Cosmetic Product RV5098A on Face Pigmentation Maintenance in Adult Vitiligo Patients.

Start: May 2024Est. completion: Jun 202550 patients
N/ARecruiting
NCT05971381AVITA MedicalRECELL® Autologous Cell Harvesting Device

Repigmentation of Stable Vitiligo Lesions Using Spray-On Skin™ Cells

Start: Aug 2023Est. completion: Jan 2025109 patients
N/ACompleted
NCT04969419PfizerExposure of skin cancer of interest

Incidence of Melanoma and Non-melanoma Skin Cancer in People With Vitiligo

Start: Jun 2021Est. completion: Apr 202375,771 patients
N/ACompleted
NCT04953338PfizerExposure of mental health condtion of interest

Mental Health Associations With Vitiligo

Start: Jun 2021Est. completion: Oct 202236,104 patients
N/ACompleted
NCT04271501AVITA MedicalMelanocyte-Keratinocyte Transplantation and Ultraviolet Lamp

Feasibility Study to Evaluate RECELL and Melanocyte Keratinocyte Transplantation Procedure for Repigmentation of Stable Vitiligo Lesions

Start: Sep 2020Est. completion: Aug 20215 patients
N/ATerminated
NCT04547998AVITA MedicalControl Intervention

Clinical Study to Investigate the Safety and Effectiveness of RECELL for Repigmentation of Stable Vitiligo Lesions

Start: Sep 2020Est. completion: Jan 202325 patients
N/ACompleted

Related Jobs in Dermatology

MSL/Senior MSL, Dermatology - Tampa, Florida

AbbVie
Remote
6h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
6h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
6h ago

Regional Sales Trainer - Dermatology (Central / West Regions)

AbbVie
Remote
7h ago

Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)

AbbVie
Remote
7h ago

Delegado Especialista Ventas Dermatología (Inmunología)

AbbVie
Remote
11h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 actively recruiting trials targeting 112,182 patients
5 companies competing in this space

Related Indications

Dermatitis, Atopic(42)Hidradenitis Suppurativa(30)Chronic Spontaneous Urticaria(21)Alopecia Areata(17)Hidradenitis Suppurativa (HS)(10)Rosacea(6)Chronic Urticaria(5)Pruritus(5)Androgenetic Alopecia(5)Uremic Pruritus(5)